Medicare insulin fills increased after Inflation Reduction Act’s $35 out-of-pocket cap
More Medicare enrollees got their insulin prescriptions filled following the Inflation Reduction Act’s $35 cap on out-of-pocket expenses for the medicine compared to the prior year, according to a new study co-authored by a University of Wisconsin researcher.
To access this content, you must purchase a Premium membership, or log in if you are a member.
